Famciclovir
Back to searchMolecule Structure
Scientific Name
Famciclovir
Description of the Drug
Famciclovir is a nucleoside analog DNA polymerase inhibitor used for the treatment of recurrent cold sores and genital herpes in healthy patients and patients with HIV, and to manage herpes zoster.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00426
http://www.drugbank.ca/drugs/DB00426
Brand Name(s)
Famciclovir, Famvir
Company Owner(s)
Mylan Pharmaceuticals Inc, Hikma Pharmaceuticals Usa Inc, Hetero Labs Ltd Unit V, Cipla Ltd, Teva Pharmaceuticals Usa, Macleods Pharmaceuticals Ltd, Novartis Pharmaceuticals Corp, Apotex Inc, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human herpesvirus 1 DNA polymerase | SINGLE PROTEIN | INHIBITOR | CHEMBL1872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2949 | |
| PharmGKB | PA449585 | |
| Human Metabolome Database | HMDB0014570 | |
| WDI | BRL-42810 | |
| DrugBank | DB00426 | |
| PubChem: Thomson Pharma | 14899331 | |
| PubChem | 3324 | |
| Mcule | MCULE-6850246103 | |
| LINCS | LSM-2990 | |
| Nikkaji | J435.369B | |
| BindingDB | 50248001 | |
| EPA CompTox Dashboard | DTXSID0023038 | |
| DrugCentral | 1128 | |
| ChemicalBook | CB0464901 | |
| GSRS | c5010b62-3a9c-4445-ba58-c5fb4ed75dfe | |
| rxnorm | FAMVIR | FAMCICLOVIR |
| PubChem: Drugs of the Future | 12013946 | |
| ChEBI | 4974 | |
| NIH Clinical Collection | SAM001246732 | |
| ZINC | ZINC000001530635 |
